After hours
⌘K
Sign in Sign up
You're reading the free version. Trader adds the live tape and alerts. Start tracking

Attovia Therapeutics, Inc.

ATTO
Transactions reported in official disclosures

162 trades

Reporting person Filed Transaction Transaction value Source
Frazier Life Sciences Xi, L.P. 10% owner Aug 6, 2026 Same-day filing Conversion Aug 6, 2026 Not reported Reported range SEC Form 4 View filing
Frazier Life Sciences Xi, L.P. 10% owner Aug 6, 2026 Same-day filing Conversion Aug 6, 2026 $0 Filed shares x price SEC Form 4 View filing
Frazier Life Sciences Xi, L.P. 10% owner Aug 6, 2026 Same-day filing Conversion Aug 6, 2026 $0 Filed shares x price SEC Form 4 View filing
Frazier Life Sciences Xi, L.P. 10% owner Aug 6, 2026 Same-day filing Conversion Aug 6, 2026 Not reported Reported range SEC Form 4 View filing
Frazier Life Sciences Xi, L.P. 10% owner Aug 6, 2026 Same-day filing Conversion Aug 6, 2026 $0 Filed shares x price SEC Form 4 View filing
You Angie Director Aug 6, 2026 2-day lag Award Aug 4, 2026 $0 Filed shares x price SEC Form 4 View filing
Gold Mitchell Director Aug 6, 2026 2-day lag Award Aug 4, 2026 $0 Filed shares x price SEC Form 4 View filing
Odrowaz Zaneta Chief Business Officer Aug 6, 2026 2-day lag Award Aug 4, 2026 $0 Filed shares x price SEC Form 4 View filing
Veiby Petter Chief Scientific Officer Aug 6, 2026 2-day lag Award Aug 4, 2026 $0 Filed shares x price SEC Form 4 View filing
Chen Hubert Chief Medical Officer Aug 6, 2026 2-day lag Award Aug 4, 2026 $0 Filed shares x price SEC Form 4 View filing
Attovia Therapeutics, Inc. Chief Financial Officer Aug 6, 2026 2-day lag Award Aug 4, 2026 $0 Filed shares x price SEC Form 4 View filing
Attovia Therapeutics, Inc. President And CEO Aug 6, 2026 2-day lag Award Aug 4, 2026 $0 Filed shares x price SEC Form 4 View filing
Frazier Life Sciences Xi, L.P. 10% owner
Conversion
Reported value range
Not reported 1,189,940 shares
Traded
Aug 6, 2026
Filed
Aug 6, 2026
SEC Form 4
View filing Trade details
Frazier Life Sciences Xi, L.P. 10% owner
Conversion
Calculated transaction value
$0 14,772,727 shares @ $0
Traded
Aug 6, 2026
Filed
Aug 6, 2026
SEC Form 4
View filing Trade details
Frazier Life Sciences Xi, L.P. 10% owner
Conversion
Calculated transaction value
$0 8,930,685 shares @ $0
Traded
Aug 6, 2026
Filed
Aug 6, 2026
SEC Form 4
View filing Trade details
Frazier Life Sciences Xi, L.P. 10% owner
Conversion
Reported value range
Not reported 961,322 shares
Traded
Aug 6, 2026
Filed
Aug 6, 2026
SEC Form 4
View filing Trade details
Frazier Life Sciences Xi, L.P. 10% owner
Conversion
Calculated transaction value
$0 11,054,544 shares @ $0
Traded
Aug 6, 2026
Filed
Aug 6, 2026
SEC Form 4
View filing Trade details
You Angie Director
Award
Calculated transaction value
$0 27,000 shares @ $0
Traded
Aug 4, 2026
Filed
Aug 6, 2026
SEC Form 4
View filing Trade details
Gold Mitchell Director
Award
Calculated transaction value
$0 27,000 shares @ $0
Traded
Aug 4, 2026
Filed
Aug 6, 2026
SEC Form 4
View filing Trade details
Odrowaz Zaneta Chief Business Officer
Award
Calculated transaction value
$0 140,000 shares @ $0
Traded
Aug 4, 2026
Filed
Aug 6, 2026
SEC Form 4
View filing Trade details
Veiby Petter Chief Scientific Officer
Award
Calculated transaction value
$0 140,000 shares @ $0
Traded
Aug 4, 2026
Filed
Aug 6, 2026
SEC Form 4
View filing Trade details
Chen Hubert Chief Medical Officer
Award
Calculated transaction value
$0 140,000 shares @ $0
Traded
Aug 4, 2026
Filed
Aug 6, 2026
SEC Form 4
View filing Trade details
Attovia Therapeutics, Inc. Chief Financial Officer
Award
Calculated transaction value
$0 140,000 shares @ $0
Traded
Aug 4, 2026
Filed
Aug 6, 2026
SEC Form 4
View filing Trade details
Attovia Therapeutics, Inc. President And CEO
Award
Calculated transaction value
$0 538,300 shares @ $0
Traded
Aug 4, 2026
Filed
Aug 6, 2026
SEC Form 4
View filing Trade details

Showing 151 to 162 of 162 entries